SEI Investments’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,623
| Closed | -$50.5K | – | 2866 |
|
|
2024
Q4 | $50.5K | Sell |
16,623
-1,815
| -10% | -$7.91K | ﹤0.01% | 2665 |
|
|
2024
Q3 | $95.7K | Sell |
18,438
-3,729
| -17% | -$18.5K | ﹤0.01% | 2559 |
|
|
2024
Q2 | $57K | Buy |
22,167
+7,628
| +52% | +$26K | ﹤0.01% | 2576 |
|
|
2024
Q1 | $71.5K | Sell |
14,539
-50,246
| -78% | -$297K | ﹤0.01% | 2533 |
|
|
2023
Q4 | $569K | Sell |
64,785
-8,824
| -12% | -$72.3K | ﹤0.01% | 2057 |
|
|
2023
Q3 | $844K | Sell |
73,609
-197,470
| -73% | -$3.8M | ﹤0.01% | 1940 |
|
|
2023
Q2 | $6.86M | Sell |
271,079
-15,072
| -5% | -$470K | 0.01% | 1059 |
|
|
2023
Q1 | $9.22M | Buy |
286,151
+114,296
| +67% | +$3.56M | 0.02% | 892 |
|
|
2022
Q4 | $3.17M | Buy |
171,855
+16,288
| +10% | +$373K | 0.01% | 1254 |
|
|
2022
Q3 | $4.2M | Buy |
155,567
+82,590
| +113% | +$1.68M | 0.01% | 1173 |
|
|
2022
Q2 | $1M | Buy |
72,977
+2,696
| +4% | +$41.5K | ﹤0.01% | 1830 |
|
|
2022
Q1 | $1.37M | Sell |
70,281
-2,646
| -4% | -$40.1K | ﹤0.01% | 1697 |
|
|
2021
Q4 | $1.19M | Buy |
72,927
+224
| +0.3% | +$3.73K | ﹤0.01% | 1779 |
|
|
2021
Q3 | $2.03M | Sell |
72,703
-3,522
| -5% | -$101K | ﹤0.01% | 1497 |
|
|
2021
Q2 | $2.26M | Sell |
76,225
-9,417
| -11% | -$272K | 0.01% | 1462 |
|
|
2021
Q1 | $2.4M | Sell |
85,642
-8,178
| -9% | -$226K | 0.01% | 1373 |
|
|
2020
Q4 | $2.66M | Sell |
93,820
-15,021
| -14% | -$389K | 0.01% | 1260 |
|
|
2020
Q3 | $2.74M | Buy |
108,841
+2,817
| +3% | +$73.9K | 0.01% | 1147 |
|
|
2020
Q2 | $2.59M | Sell |
106,024
-407
| -0.4% | -$8.03K | 0.01% | 1161 |
|
|
2020
Q1 | $1.57M | Sell |
106,431
-5,020
| -5% | -$104K | 0.01% | 1256 |
|
|
2019
Q4 | $1.81M | Buy |
+111,451
| New | +$1.73M | 0.01% | 1386 |
|
Other funds holding RVNC
SEI Investments's RVNC Position: Q1 2025 in Review
SEI Investments sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 16,623 shares — an estimated $50.5K sold.
SEI Investments first reported a position in RVNC in Q4 2019 and held it in 21 quarters. The position peaked at $9.22M in Q1 2023. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.
- SEI Investments reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
- SEI Investments sold 16,623 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $50.5K.
- SEI Investments first reported a position in Revance Therapeutics, Inc. in Q4 2019 and held it in 21 quarters.
- SEI Investments's Revance Therapeutics, Inc. position peaked at $9.22M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.
Based on SEI Investments's 13F filing for Q1 2025, filed 13 May 2025.